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Background
Increased permeability and interstitial and pulmonary edema are prominent features of acute lung injury/acute respiratory distress syndrome (ARDS), and Vascular Endothelial Growth Factors (VEGFs) and their receptors have been implicated in the regulation of vascular permeability in many organ systems, including the lung [1] . On the other hand, a decrease in lung capillary density has clearly been demonstrated during ARDS [2] , which may lead to an increase in alveolar dead space, a factor associated with increased lethality [3] . VEGF has been demonstrated to be a major physiological survival factor for endothelium [4] , which is abundantly secreted in healthy lung [5] . We and others evidenced low levels of VEGF in the lungs of patients with ARDS [6, 7] . This VEGF decrease may have contributed to vascular injury inasmuch as we subsequently demonstrated a negative relationship between VEGF concentration in lung homogenate and the number of endothelial cells undergoing apoptosis in lung tissue of patients suffering from ARDS [8] . VEGF (or VEGF-A) is a highly conserved, dimeric, heparin-binding glycoprotein (molecular weight 46 kDa). At least four different VEGF transcripts resulting from alternate splicing of a single gene have been identified in human cells. VEGF121 and VEGF165 are secreted in soluble form, whereas VEGF189 and VEGF206 remain cell-surface associated or are primarily deposited in the extracellular matrix. VEGF seems to specifically affect endothelial cell growth, survival, and permeability. In the lung, VEGF is expressed primarily by epithelial cells and macrophages.
The biological activity of VEGF is dependent on interaction with specific receptors (VEGF-R1, 2, 3), which are expressed not only by endothelial cells but also by activated macrophages and alveolar type II epithelial cells. Endothelial survival is mediated via VEGF-R2/KDR [9] .
The aim of this study was to determine whether VEGF is a main factor determining 4 endothelial and animal survival during acute lung injury. To this end, we used VEGF adenoviral-mediated transduction during hyperoxia-induced injury inasmuch as hyperoxia has been associated with predominant endothelial injury [10] .
Materials and Methods
Design of the study
Preliminary set of experiments: a time course study of lung VEGF expression after adenoviral-transduction has been previously published by our laboratory [11] . Based on these results, adenoviral transduction was conducted 48 hours before hyperoxia exposure inasmuch as significant levels of human VEGF are already expressed in lungs of rats in accordance with the results obtained by Kaner and colleagues [12] . This time point was chosen based on the time-course study under hyperoxia of lung histopathology published by Crapo and colleagues demonstrating significant endothelial injury whereas no mortality is still observed [10] . In this set of experiments, additional rats challenged with either Ad.VEGF or Ad.Null were evaluated under normoxia at similar timepoint in order to evaluate the respective effects of Ad. VEGF and hyperoxia on indexes of lung injury.
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Recombinant Adenovirus Vectors
All Ad vectors were E1a , partial E1b , partial E3 based on the Ad5 backbone, containing a transgene (AdVEGF165) or no transgene (AdNull) under control of the cytomegalovirus immediate-early promoter/enhancer in the E1a position [12] . AdVEGF165 expresses the human VEGF165 cDNA. All adenovirus vectors were propagated in 293 cells, purified by
CsCl gradient centrifugation, dialyzed, and stored at 80°C. Adenovirus vectors were provided by the Vector Core of the University Hospital of Nantes supported by the Association
Française contre les Myopathies (AFM).
Animals and Delivery of Adenovirus Vectors to the Lungs
Male Wistar rats (200 to 220 g body weight) were used for all studies. All animal care and procedures were in accordance with institutional guidelines. Ad.VEGF, or Ad.Null as the control, was diluted before use with sterile saline (Phosphate buffer saline, PBS purchased from Gibco), pH 7.4, in a final volume of 120 µl. Rats were anesthetized with intraperitoneal ketamine (7 mg/100 g) and xylazine (1 mg/100 g). Intratracheal instillation of 120 µl/rat of diluted Ad.VEGF or Ad.Null was performed using a standard procedure, as previously described [11] .
Animal Exposure to Hyperoxia
Two days after intratracheal Ad.VEGF (5.10 9 and 10 10 VP) or Ad.V152 (10 10 VP) administration, the rats were exposed to >95% oxygen in a Plexiglas hyperoxia chamber. The flow of gas was kept constant at 8 L/min. The inspired fraction of oxygen was checked using a gas analyzer (Radiometer ABL330, Copenhagen) at the end of each experiment. The rats had free access to food and water and were housed at room temperature. 
Bronchoalveolar lavage and differential cell count
After intraperitoneal administration of pentobarbital (60 mg/ kg), the abdominal aorta was cut and a median sternotomy was performed. The left lung was used for bronchoalveolar lavage (BAL), which was carried out by flushing the lung with sterile, pyrogen-free, physiological saline via a tracheal cannula (one 5 ml and two 2.5 ml aliquots). The recovered fluids were pooled. The total number of cells was counted using a standard hemocytometer. Cytospin preparations were made using a Shandon 3 cytocentrifuge (Shandon, France). The cells were fixed and stained with Diff-Quick kit (Dade Behring, France). Differential counts on 200 cells were done using standard morphological criteria.
Tissue Harvesting and Processing
After BAL procedure, the lung tissue was inflated with paraformaldehyde 4% and fixed overnight in paraformaldehyde. Tissues were then dehydrated through serial ethanol concentrations of 70%, 95% and 100%. Tissues were then processed through xylene and embedded in paraffin. Five micron-sections were cut and placed on positively charged slides (Super Frost Plus). To perform CD31 immunohistochemistry, another series of lungs was fixed in Tissue-Tek (Sakura) /PBS (1:1) and frozen in liquid nitrogen. Five-to six-micronthick cryosections were then performed with cryostat (JUNG CM300, Leica).
Quantification of Lung Wet/Dry Weight Ratio
The right lung was used for edema assessment and tissue homogenate preparation. A lung sample was immediately weighed and then placed in a dessicating oven at 65°C for 48 h, at which point dry weight was achieved. The ratio of wet/dry weight was used to quantify lung water content, an index of lung edema. The remaining tissue was fixed in liquid nitrogen to allow subsequent homogenate preparation.
VEGF concentration in lung homogenates
A lung tissue specimen was thawed and homogenized in lysis buffer (10 mg/ml) containing 0.5% Triton X100, 150 mM NaCl, 15 mM Tris, 1 mM CaCl, and 1 mM MgCl (pH 7.4).
Homogenates were incubated on ice for 30 min, then centrifuged at 12 000 g for 20 min at 4°C. Supernatants were collected then stored at -80°C for assays. The concentration VEGF was determined using an human sandwich enzyme-linked immunosorbent assay (ELISA)
according to the manufacturer's instructions (R&D Systems, France). We and others previously demonstrated that this human VEGF ELISA kit cross reacts with rat VEGF [5, 13] .
Immunohistochemistry: CD31 staining
Purified monoclonal mouse anti-rat CD31 (BD Pharmingen) antibody was used to quantify the microvascular bed in our experiments. Briefly, frozen slides were allowed to come to room temperature and were then fixed with paraformaldehyde 1% in PBS, rinsed and put in ethanol / acetic acid (2:1) for 5 min at -20°C. Slides were incubated in 3% H 2 O 2 for 15 min to quench endogenous peroxidase and rinsed. Non specific sites were blocked with Goat serum 2% in PBS tween 0.05% at RT. Monoclonal mouse anti-rat CD31 antibody was incubated (diluted 1/100 in PBS/BSA 1%) for 2 hours at RT in humidified chamber. After rinsing, second antibody goat anti-mouse IgG from Sigma (diluted 1/100) was processed for 30 min in humidified chamber at RT. Slides were labeled with ExtrAvidin peroxidase for 30 min. 3,3'-diaminobenzidine tetrahydrochloride dihydrate (DAB, Sigma) was used to visualize labeled antibody.
TUNEL staining
In situ detection of apoptotic cells was evaluated by terminal deoxynucleotidyl transferase (TdT)-mediated dUTP nick end labeling (TUNEL) using a commercially kit (ApopDETECT, QBiogene, France), according to the manufacturer's protocol. Briefly, after paraffin removal in xylene, the sections were rehydrated and exposed to proteinase K (Promega, USA).
Endogenous peroxidase was quenched with 3% H 2 O 2 . Residues of digoxigenin-nucleotide were catalytically added to the DNA by TdT to the 3'-OH ends of DNA at 37°C for 1 hour. 
Histological analyses and quantification
All the histological evaluations were performed in blind fashion. Inasmuch as initial histological evaluation showed patchy areas with cellular proliferation, all subsequent quantitative analyses were performed with and without selection of areas of obvious cellular proliferation. This was justified by the fact that quantitative analysis of these areas could induce a bias, our aim was to evaluate whether adenoviral transduction had a biological effect in the whole lung (especially in areas without cellular proliferation). The inflammatory response was assessed using a previously described empiric semi-quantitative scale [14] based on inflammatory-cell type and location (alveoli, bronchi, or blood vessels). The extent of 9 inflammation was scored on a 0-4 scale as follows: 0, none; 1, small scattered areas; 2, <10%; 3, 10-50%; and 4, >50% of section area.
Statistical analysis
The data are expressed as means ± standard error of the mean (SEM). 
Results
Effect of Ad.VEGF transduction on rat survival under hyperoxia
All the Ad.Null 
Wet-to-dry lung weight ratio. Under normoxia, transduction with Ad.VEGF induced lung
edema as compared to Ad.Null transduction. Under hyperoxia, lung edema was observed in control rats (Ad.Null) whereas it did not further increase in rats challenged with Ad.VEGF (figure 8).
Discussion
The role of VEGF and related molecules in acute lung injury/ARDS remains controversial as stated in a recent review [1] . In this experimental study, we tried to explore its role in hyperoxia-induced lung injury. Transduction of VEGF-A was effective since a dramatic increase in concentration of the growth factor was evidenced in lung homogenates, an inhibition of endothelial loss was observed in lung tissue and since obvious endothelial proliferation was evidenced in some areas. These results are consistent with those of Factor and colleagues who demonstrated that acute hyperoxic lung injury does not impede adenoviral-mediated alveolar gene transfer [16] . Ad.Null was considered in our study as a reference similar to non-treated group on the basis of our previous works since adenovirus vector without transgene used is not deleterious [11, 15] . Hyperoxia-mediated lung injury results in both endothelial and epithelial injuries, the former being predominant [10] .
Similarly to epithelial injury, endothelial injury during hyperoxia may be related to both apoptosis and necrosis [17] . It is difficult to evaluate their respective contributions in vivo. In our model we found a diffuse increase in apoptotic cells (TUNEL) under hyperoxia as compared to normoxia, which is in agreement with the recent study of He and colleagues [18] .
The increase in apoptosis was milder in the areas of endothelial proliferation that is probably related to a local effect of VEGF transduction. It has to be noted that only one marker of apoptosis was used, which constitutes a limitation of this study. Hyperoxia-induced injury led to a decrease in vascular bed as previously evidenced [10] . VEGF transduction prevented this decrease even when areas of patchy cell proliferation were not taken into account for the quantification, arguing for a role of apoptosis-induced diffuse vascular injury in this model. In patients with ARDS we and others found a decrease in VEGF concentration in bronchoalveolar lavage fluid [6, 7] , and more recently in lung tissue [8] . Hyperoxia-induced lung injury has consistently been associated with a decrease in lung VEGF mRNA [26] [27] [28] .
Along this line, we previously demonstrated a negative relationship between decreased VEGF
During hyperoxia, VEGF protein can decrease in tissue while its concentration in epithelial lining fluid depends on the time of assessment [27, 28] . In our study, the decrease in VEGF protein concentration under hyperoxia in lung tissue was not significant, which may reflect this complex time-dependency. Our results do not suggest that VEGF will constitute a promising rescue therapy during ARDS.
In conclusion, we demonstrate that despite evidence of functional consequences such Lung sections were examined in a blind manner to quantify inflammatory cell recruitment.
Three tissue sections (10 fields in each section) were analyzed. Effect of administration of Ad.VEGF 10 10 VP or Ad.Null 10 10 VP (control vector) on wet to dry weight ratio under 21% or ≥95% oxygen. Lungs were harvested two days after air or oxygen exposure and proceed as described in Methods (n = 5 for each group). * P ≤ 0.05. 
